![]() |
Volumn 14, Issue 1, 2008, Pages 83-85
|
It's only a pharmacoeconomic model - Believe it or not
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BISMUTH;
CLARITHROMYCIN;
CYCLOOXYGENASE 2 INHIBITOR;
ENTECAVIR;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LAMIVUDINE;
METRONIDAZOLE;
MISOPROSTOL;
PROTON PUMP INHIBITOR;
TETRACYCLINE;
ACCURACY;
CANCER REGISTRY;
CANCER SCREENING;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG UTILIZATION;
EDITORIAL;
ERADICATION THERAPY;
HEALTH ECONOMICS;
HEALTH INSURANCE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HEPATITIS B;
HUMAN;
INFLAMMATORY DISEASE;
MANAGED CARE;
MATHEMATICAL MODEL;
MULTIPLE SCLEROSIS;
PREDICTION;
STATISTICAL MODEL;
UTERINE CERVIX CANCER;
|
EID: 40149100013
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: 10.18553/jmcp.2008.14.1.83 Document Type: Editorial |
Times cited : (3)
|
References (25)
|